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A Fibronectin Peptide Redirects PDGF-BB/PDGFR
Complexes to Macropinocytosis-Like Internalization
and Augments PDGF-BB Survival Signals
Jia Zhu1, Fubao Lin2, Deborah A. Brown1 and Richard A.F. Clark2,3
Growth factor–binding domains identified in various extracellular matrix proteins have been shown to regulate
growth factor activity in many ways. Recently, we identified a fibronectin peptide (P12) that can bind platelet-
derived growth factor BB (PDGF-BB) and promote adult human dermal fibroblast (AHDF) survival under stress.
In vivo experiments in a porcine burn injury model showed that P12 limited burn injury progression, suggesting
an active role in tissue survival. In this report, we explored the molecular mechanism of this peptide in ADHF
under nutrient deprivation. Our results showed that P12 acted like some cell-penetrating peptides in that it
redirected ligand-bound PDGF receptor (PDGFR) from the clathrin-dependent endocytic pathway to a slower,
macropinocytosis-like pathway. P12 slowed internalization and degradation of PDGF-BB, augmented its survival
signals, and promoted cell survival after nutrient removal. Our findings demonstrate a mechanism for a potential
therapeutic peptide that increases cell and tissue survival by acting as a cofactor to PDGF-BB.
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INTRODUCTION
Many growth factor–binding sites have been identified in
extracellular matrix (ECM; Macri et al., 2007). They may act as
reservoirs and serve to sequester and protect growth factors
from degradation, and/or enhance their activity (Schultz and
Wysocki, 2009). Recently, our lab identified a peptide P12
from the first type III repeat of fibronectin (FN) with significant
binding affinity to platelet-derived growth factor BB (PDGF-
BB; Lin et al., 2013). Previously, we demonstrated that P12
can work as a cofactor of PDGF-BB to promote adult human
dermal fibroblast (AHDF) survival under reactive oxygen
species–induced or tunicamycin-induced endoplasmic reticu-
lum stress. P12 was also shown to limit burn injury progres-
sion in a rat hot comb burn model (Lin et al., 2013). These
studies have been confirmed in a porcine hot comb
burn model (Clark et al., 2011); however, the molecular
mechanism of P12 remains unclear.
Much of the tissue damage in burn patients results from
injury progression, a dynamic process of tissue death around
the burned area occurring in the first 24 to 48 hours after burn
(Lanier et al., 2011). Others in our laboratory have shown
significant blood vessel plugging with red blood cells in the
first few hours after burn injury (Zhou et al., 2011). This
occlusion likely causes hypoxia and nutrient deprivation in
peri-burn tissue. In addition, a band of apoptosis in the deep
dermis occurred by 24 hours after burn injury (Lanier et al.,
2011). This suggests that progressive tissue death characteristic
of burn injury progression is related to nutrient deprivation/
hypoxia in peri-burn tissue.
A clue to its mechanism of action is that P12 is a 14-residue
peptide with an isoelectic point of 11.5. Such a structure
resembles cell-penetrating peptides (CPPs). CPPs are highly
cationic peptides of 10 to 20 amino acids. Many, but not all,
CPPS initially bring cargo (proteins, peptides, nucleic acids,
and so on) into mammalian cells in an energy- and tempera-
ture-dependent manner with characteristics consistent with
macropinocytosis (Kaplan et al., 2005; Said Hassane et al.,
2010; Schmidt et al., 2010). Subsequently, through some
poorly defined process(s), CPPs either penetrate vesicular
membranes or are otherwise released from vesicles. In the
first step of internalization, such CPPs appear to interact
electrostatically with cell surface proteoglycans leading to
endocytic internalization (Madani et al., 2011). As P12 fits the
structural definition of a typical CPP (4 cationic residues out of
a total of 14), it may affect endocytic entry of PDGF-BB and its
receptor.
Endocytic entry of growth factor receptors following ligand
binding has an important role in the regulation of growth
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factor signaling (Sorkin and von Zastrow, 2009). After internali-
zation, EGF can still generate survival signals from endosomes
(Miaczynska and Bar-Sagi, 2010; Dobrowolski and De Robertis,
2012). Moreover, extracellular signal–regulated kinases 1/2
activation is dependent on endocytosis of the EGFR (Galperin
and Sorkin, 2008). Importantly, route of entry, downstream
adaptor/signal proteins present, and resident-time in endocytic
vesicles before degradation or recycling to the plasma
membrane dictate the amplitude, specificity, and duration of
signal (Sorkin and von Zastrow, 2009). Similar to EGF/EGFR,
endosomal signaling can occur from ligand-bound PDGF
receptor (PDGFR) and is sufficient for cell survival (Wang
et al., 2004). Furthermore, different endocytic pathways used to
internalize PDGF/PDGFR generate differential signals, leading
either to proliferation, or migration (De Donatis et al., 2008).
Interestingly, the macropinosome, as a signaling platform
for PDGF-BB, can generate stronger survival signals than other
locations (Schmees et al., 2012). In fact, H-Ras-transformed
fibroblasts can use macropinocytosis to generate enhanced
PDGF-BB survival signals. The increased localization of
PDGFR in macropinosomes led to stronger receptor
activation, prolonged Akt phosphorylation, and enhanced
cell survival (Schmees et al., 2012).
Although PDGF-BB induces macropinocytosis, ligated
PDGFR is mainly internalized through clathrin-mediated
endocytosis (Kapeller et al., 1993) or at high PDGF-BB dose
through, raft/caveolin-mediated endocytosis (De Donatis
et al., 2008). During both clathrin- and caveolin-mediated
endocytosis, the GTPase dynamin is required for vesicle
fission, whereas macropinocytosis occurs independently of
dynamin activation (Mayor and Pagano, 2007; Lim and
Gleeson, 2011). In this report, we investigated the effect of
P12 on PDGF-BB endocytosis and PDGF signaling. Our
results suggest that by shifting the balance between clathrin-/
dynamin-dependent and -independent endocytic pathways,
P12 slowed internalization and degradation of PDGF-BB,
augmented survival signal, and promoted cell survival under
nutrient-removal stress.
RESULTS
P12 enhanced PDGF-BB ability to support AHDF survival under
nutrient deprivation
As P12 worked synergistically with PDGF to promote AHDF
survival under reactive oxygen and endoplasmic reticulum
stress (Lin et al., 2013), we investigated whether P12 had a
similar effect under acute nutrient deprivation. For this
purpose, we used initially a nutrient deprivation system (Wei
et al., 2008) with or without hypoxia (1% oxygen). As an
indicator for cell viability we used the XTT assay, which
measures mitochondria dehydrogenase activity. Although P12
by itself does not stimulate cell metabolism (Supplementary
Figure S1 online), P12 enhanced the ability of PDGF-BB to
support AHDF in Hank’s balanced salt solution (HBSS) devoid
of all growth factors and amino acids (Figure 1). AHDFs were
rounded or shriveled after 3 days under these starvation
conditions, even in the presence of PDGF-BB (Figure 1a). In
contrast, AHDFs treated with PDGF-BBþP12, but not PDGF-
BB±sP12, were well spread with a healthy appearing
morphology (Figure 1a). Cell metabolism dropped significantly
after nutrient deprivation compared with cells in Dulbecco’s
modified Eagle’s medium (OD450¼ 1.6). However, P12
increased cell metabolism at all PDGF-BB doses (Figure 1b)
and protected cells from nutrient deprivation-induced apop-
tosis (Figure 1c). Almost 40% of the AHDFs underwent
apoptosis after 3 days of starvation. Although PDGF-BB
reduced apoptosis to 30%, P12/PDGF-BB treatment lowered
apoptosis to o10% (Figure 1c). To determine whether cells
treated with P12/PDGF-BB survived 72 hours starvation better
than cell treated with PDGF-BB alone, cells were switched to
full-serum medium and assayed by the XTT 24 hours later
(Figure 1d). Indeed metabolism was significantly higher with
P12/PDGF-BB than PDGF-BB alone. Similar results were
obtained with cells cultured under nutrient deprivation con-
ditions and hypoxia (1% oxygen; data not shown).
P12 with Alexa488 cargo was internalized into endocytic
vesicles
P12 is similar to a CPP in structure (10–20 amino acids long;
rich in arginine and lysine). Many, but not all, CPP attached to
cargo can enter cell through macropinocytosis followed by
endosomal escape into cytoplasm (Schmidt et al., 2010). Thus,
we studied whether P12 fused with Alexa488 can enter cells
through endocytosis. To test this, Cys-tagged P12 was labeled
with Alexa Fluor 488 (P12-Alexa488), incubated with AHDF,
and cells were examined by 1mm step-sections with
immunofluorescence confocal microscopy (Figure 2a). Impor-
tantly, N- or C-terminal blocking with amidation, acetylation,
or Cys-tagging did not change P12 bioactivity (data not
shown). P12-Alexa488 was detectable in endocytic structures
within 1 hour at 37 1C. Fluorescence-activated cell sorting
analysis demonstrated that Alexa488 internalization required
P12, as Alexa488 itself did not enter AHDF (Figure 2b). To
differentiate between cell association and uptake, cells were
trypsinized to remove surface P12 before the fluorescence-
activated cell sorting analysis.
To further characterize the P12 internalization pathway,
P12-Alexa488 was incubated with cells at low temperature,
with ATP depletion, or chondroitin sulfate removal as inter-
nalization of highly cationic peptides by macropinocytosis
requires active metabolism and interaction with cell surface
glycosaminoglycans (Rullo et al., 2011). Alexa488-P12 uptake
was almost completely inhibited at 4 1C or when cells were
pre-incubated with sodium azide and deoxy-glucose to
deplete cellular ATP, and greatly inhibited after digestion
with chondrointinase ABC (Figure 2c and d). Together these
data support the contention that P12 can carry cargo into
endocytic vesicles.
P12 slowed PDGF-BB/PDGFR-b internalization/degradation
Although PDGF-BB can induce macropinocytosis (Schmees
et al., 2012), activated PDGFR is mainly internalized through
clathrin-mediated endocytosis (Kapeller et al., 1993). By
contrast, when molecules are internalized through macro-
pinocytosis it is a slower process than clathrin/dynamin
endocytosis (Jones, 2007; Al Soraj et al., 2012). As P12 is a
small, highly cationic peptide that can enter cells through an
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energy- and temperature-dependent pathway and binds
strongly to PDGF-BB, it is possible that P12 can change the
internalization pathway of PDGF-BB/PDGFR- b and thereby
affect the internalization/degradation rate. To test this
possibility, we analyzed Alexa Fluor-350-labeled PDGF-BB
uptake in HBSS±P12. Importantly, Alexa Fluor-350 did not
affect PDGF-BB bioactivity (Supplementary Figure S2a online).
After incubation with AHDF for 1 hour at 37 1C, cellular
uptake (indirectly measured by residual PDGF in the medium)
was slower in the presence of P12 for both labeled and
unlabeled PDGF-BB (Supplementary Figure S2b and c online).
Internalization through clathrin-mediated endocytosis
(Muratoglu et al., 2010) and subsequent receptor degrada-
tion is a negative regulation that prevents sustained signaling
from PDGFR-b on the cell surface (Heldin and Westermark,
1999). However, P12 may have altered the internalization
of PDGF-BB pathway in such a way to slow the rate
of internalization, thus leaving more PDGF in the medium.
In order to determine whether PDGFR-b degradation is
also affected by P12, we next used western blot and
immunofluorescence to analyze PDGFR-b levels in cells.
After PDGF-BB±P12 treatment in HBSS, we found, in fact,
that P12 significantly slowed PDGFR-b degradation (Supple-
mentary Figure S2d–f online).
Taken together, the results showed that P12 slowed the
internalization/degradation of both PDGF-BB and PDGFR-b.
One possible explanation of these findings is that P12 binding
to PDGF-BB interfered with receptor recognition. However,
Biacore experiments showed that the interaction between
PDGF-BB and PDGFR extracellular domain was not affected
by the presence of P12 (Supplementary Figure S3 online). An
alternate possibility is that P12 slowed PDGF-BB/PDGFR-b
internalization and degradation by shifting endocytosis from a
clathrin-mediated mechanism to a slower route such as
macropinocytosis.
P12 shifted endocytosis of PDGF-BB/PDGFR-b to a
macropinocytosis-like pathway
To study how P12 altered PDGF-BB/PDGFR-b entry into the
cell, Alexa Fluor 488-labeled PDGF-BB was attempted. How-
ever, the sensitivity was too low at physiological concentra-
tions of PDGF-BB. We next tried Q-dot-labeled PDGF-BB
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Figure 1. P12þ platelet-derived growth factor (PDGF) promoted adult human dermal fibroblast (AHDF) survival under nutrient deprivation. AHDFs were
treated with PDGF±P12 in Hank’s balanced salt buffer (HBSS) for 72 hours. Unless otherwise indicated, all experiments were performed in HBSS with 1 nM PDGF
and 10mM P12. (a) Cell morphology as judged by phase contrast microscopy. (sP12¼ scrambled P12). Bar¼40mm. (b) Cell metabolism was measured by the XTT
assay (*Po0.05 compared with PDGF alone, n¼ 6). Data are shown as mean±SD. (c) Apoptosis was measured by the TUNEL assay. %TUNELþ ¼TUNEL
positive/4,6-diamidino-2-phenylindole positive. In all, 4800 cells counted (*Po0.05 compared with PDGF alone, n¼6). Data are shown as mean±SD. (d) After
72 hours of nutrient deprivation, cells were rescued with 10% fetal bovine serum for 24 hours and metabolism was measured by the XTT assay (*Po0.05
compared with PDGF alone, n¼ 6). Data are shown as mean±SD. DMEM, Dulbecco’s modified Eagle’s medium; OD, optical density.
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(Lidke et al., 2004, 2007) However, the PDGF-Q-dot complex
was internalized by macropinocytosis probably secondary to
the large size of Qdots (data not shown). Therefore, a MCF-7
cell line expressing PDGFR-green fluorescent protein (GFP;
Reddi et al., 2007) was used to track PDGF-BB/PDGFR-b
complexes with 70 kD dextran-Texas red (TR-dextran) as a
macropinosome marker (Kerr and Teasdale, 2009). In controls
(HBSS without PDGF-BB), most PDGFR-GFP signal was
localized uniformly on the cell surface (Figure 3a; HBSS,
control). When PDGF-BB was added, PDGFR-GFP signal was
observed in green vesicles, despite PDGF-BB-induction of
macropinocytosis denoted by red vesicles (Figure 3a; HBSS,
PDGF). However, PDGFþ P12 promoted colocalization of
PDGFR and TR-dextran as noted by yellow vesicles (Figure 3a;
HBSS, PDGFþP12), consistent with the hypothesis that P12
shifted PDGF-BB entry to a macropinocytosis-like pathway. In
HBSS, P12 alone did not induce MCF-7 cell macropinocytosis
(Supplementary Figure S4 online). Furthermore, scrambled
P12 (sP12) had no significant effect on GFP-PDGFR coloca-
lization with TR-dextran (Figure 3b).
To further verify that P12 shifted the endocytic pathway of
PDGFR, we used dynasore (Dyn), a small chemical inhibitor
of dynamin that blocks clathrin- and caveola-dependent
endocytosis (Macia et al., 2006). In the presence of Dyn,
PDGF-BB could only stimulate minimal internalization of
PDGFR-GFP. However, P12/PDGF enhanced uptake into
vesicles that colocalized PDGFR-GFP with TR-dextran
(Figure 3). Complementary to this, we observed in AHDF that
PDGFR-b internalization/degradation was slowed significantly
by Dyn, and that P12 partially overcame the Dyn block of
receptor degradation (Supplementary Figure S5 online).
Besides Dyn, clathrin heavy chain knockdown (CHC KD)
blocks clathrin-mediated endocytosis (Huang et al., 2004).
Therefore, to further define P12/PDGF-BB trafficking into
cells we used small interfering RNA (siRNA) to KD CHC
expression in MCF-7 cells (Supplementary Figure S6 online).
Indeed, PDGF-BB-stimulated PDGFR-b entry into the cell was
significantly suppressed by CHC KD, but addition of P12
overcame this block (Figure 3). Together, these results strongly
support the contention that P12 shifted PDGF-BB/PDGFR-b
entry into cells from clathrin-mediated endocytosis to a
macropinocytosis-like pathway.
P12 enhanced PDGFR-b activation and p85 recruitment
The endocytic route of PDGF-BB/PDGFR-b effects down-
stream signaling (De Donatis et al., 2008). Furthermore,
PDGF-BB can generate a more robust survival signal
through macropinocytosis compared with clathrin-mediated
endocytosis (Schmees et al., 2012). To determine how
P12 affects PDGFR signaling, we first examined the effect of
P12 on PDGFR-b activation. AHDF were treated with
PDGF±P12 in HBSS followed by isolation of internalized
AF-488
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Figure 2. Alexa488-P12 was endocytosed by an energy-dependent pathway. All experiments were performed with 10% fetal bovine serum in Dulbecco’s
modified Eagle’s medium (DMEM). (a) Adult human dermal fibroblasts (AHDF) were treated with 1mM of Alexa488-P12 for 1 hour at 37 1C then cross-section
imaged at 0.74mm. Bar¼ 10mm. (b) AHDF were treated with 0.1,1, 10, or 50mM of Alexa488-P12 or 1mM Alexa Fluor-488 for 1 hour at 37 1C, then trypsinized
and analyzed by flow cytometry. (c) AHDF were treated with 1mM of Alexa488-P12 after no pretreatment, ATP depletion with 10 mM of sodium azide and
2-deoxyglucose, or 0.1U ml chondroitinase ABC digestion. Red signal is Cellmask membrane stain. Bar¼ 40mm. (d) Quantification of vesicles per cell.
Over 50 cells were counted for each condition (*Po0.05 compared with 37 1C, n¼3). Data are shown as mean±SD.
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PDGFR-b (see Materials and Methods section). Enhanced
PDGFR-b activation as judged by phosphorylation at Tyr751
was observed in cells treated with P12/PDGF-BB compared
with those treated with PDGF-BB alone (Figure 4a). Further-
more, when biotinylated PDGFR-b was pulled-down by
streptavidin beads and probed with an antibody to the
phosphatidylinositol 3 kinase (PI3K) p85 subunit, we observed
increased recruitment of p85 to PDGFR in P12/PDGF-BB–
treated cells compared with cells treated with PDGF-BB alone
(Figure 4b). These data suggest that P12 enhanced PDGFR-b
activation by PDGF-BB and increased PI3K signaling that is
required to activate downstream survival pathways (Klinghoffer
et al., 1996).
P12 prolonged Akt phosphorylation induced by PDGF-BB
To test whether there is a link between differential PDGF-BB
trafficking into the cell and enhanced cell survival signals, we
studied whether P12 also affected PDGF-BB survival signals
downstream of PI3K. The Akt/PI3K signaling pathway is one of
the major signaling pathways activated by PDGF-BB and is
important for cell survival under conditions including oxida-
tive stress, endoplasmic reticulum stress, and nutrient depriva-
tion (Franke, 2008). Based on increased PDGFR-b activation
and p85 recruitment in P12-treated cells, it is possible that P12
can enhance PDGF-BB signaling downstream in the Akt/PI3K
pathway under nutrient deprivation. Indeed, P12/PDGF-BB,
compared with PDGF-BB alone, prolonged Akt phosphorylation
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Figure 3. P12 increased platelet-derived growth factor BB (PDGF-BB)/PDGF receptor- b (PDGFR-b) internalization into macropinosomes. (a) MCF-7 cells
expressing green fluorescent protein (GFP)-PDGFR-b were treated with TR-dextran and 1 nM PDGF-BB±10mM P12 for 15 minutes in Hank’s balanced salt buffer
(HBSS), and then analyzed by confocal microscope. For dynamin inhibition, cells were pre-incubated with 80mM dynasore for 1 hour in serum-free-Dulbecco’s
modified Eagle’s medium (DMEM; see Supplementary Figure S6 online for clathrin heavy chain knockdown (CHC KD). Bar¼ 10mm. (b) Colocalization
of red and green signal was used to indicate the degree of colocalization between PDGFR-b and TR-dextran (threshold for both channels were set to 70). In all,
4100 cells per condition were counted. The bar graph represents the colocalization index, calculated as the number of yellow pixels divided by the number of
yellowþ green pixels. Experiments were repeated three times (*Po0.05 compared with PDGF alone, n¼ 3). Data are shown as mean±SD.
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(Ser473) and inhibited c-Jun N-terminal kinase phosphory-
lation (T183/Y185; Figure 4c and d) while not effecting p38
phosphorylation and elF4e protein levels 1 hour after treat-
ment. Similar results were obtained with AHDF (AG09605)
from another individual (data not shown). Importantly, P12
alone did not affect PDGFR pathway signaling (Supplementary
Figure S7 online).
As prolonged Akt and decreased c-Jun N-terminal kinase
phosphorylation are linked to increased cell survival under
starvation (Rovida et al., 2008), these data are consonant with
the posit that P12 promotes cell survival by modulating PDGF-
BB signaling.
To put this in context of wound healing, we tested
biologically relevant doses of PDGF-BB (Supplementary
Figure S8 online). P12 increased p-Akt at PDGF-BB levels
observed in both acute wound fluid and in serum (Raines and
Ross, 1982; Baker et al., 2008). As an important control, P12,
which does not bind EGF (data not shown), did not affect EGF-
stimulated Akt phosphorylation (Supplementary Figure S8
online).
Previous reports demonstrated that Dyn can block sustained
p-Akt and p-extracellular signal–regulated kinases 1/2 signal-
ing from colony-stimulating factor-1 (Huynh et al., 2012). In
our system, we observed a similar inhibition of PDGF-BB-
stimulated p-Akt signal in the presence of Dyn. However,
addition of P12 bypassed the dynamin blockade and restored
PDGF-BB signaling to control levels (Supplementary Figure S9
online). These results supported the contention that P12 can
mediate PDGF signaling through a dynamin-independent
pathway.
P12 bypassed CHC KD to stimulate cell metabolism
CHC KD has been shown to block clathrin-mediated endo-
cytosis of growth factor receptors (Huang et al., 2004). Here
we used siRNA to KD the CHC in AHDF cells and measured
cell metabolism after 3 days of nutrient deprivation
(Figure 5a). Mock transfection had little or no effect on
either PDGF- or PDGF/P12-sustained metabolism (Figure 5b,
compared with Figure 1a). In contrast, PDGF-stimulated
cell metabolism dropped in the KD cells almost to control
level, whereas P12 abrogated this effect (Figure 5c). Taken
together, our results are consonant with P12 shifting PDGF-BB
trafficking from clathrin-mediated endocytosis to a macropi-
nocytosis-like pathway, thereby generating stronger survival
signals.
DISCUSSION
Numerous clinical trials with recombinant growth factors have
been largely disappointing. Most growth factors alone have
minimal to no activity toward improving wound repair.
Interestingly, the trials that demonstrated growth factor benefit
all contained a biomaterial carrier, suggesting that spatio-
temporal control over growth factor bioactivity is crucial
to achieve tangible therapeutic effect (Lee et al., 2011).
Internalized proteins
15 min 30 min
– –
++ +
++
+
PDGFR
PD
GF
p-PDGFR
p-PDGFR at 15 min
P12:
p85 at 15 min
*
*40,000
30,000
30,000
Ba
nd
 in
te
ns
ity
Ba
nd
 in
te
ns
ity
20,000
20,000
10,000
0
10,000
0
p-AKT
p-SHP2
p-ERK1/2
GAPDH
p-PDGFR
P12
PDGF
PD
GF
-P1
2
PD
GF
PD
GF
-P1
2
PDGF:
PDGFR
PDGF
PDGF
kDa
60
60
38
25
37
PDGF+P12
PDGF+P12
PDGF+sP12
PDGF+sP12
0 1 2 40 1 2 40 1 2 4 (h)
p-Akt
Akt
p-ERK1/2
p-JNK
p-p38
elF4e
GAPDH
p85
– – – + +
+++++
0 15 15 6060 (min)
IP: PDGFR
p-Akt band intensity
45,000
40,000
35,000
30,000
25,000
20,000
15,000
10,000
5,000
*
Ba
nd
 in
te
ns
ity
Treatment time (h)
0
0
1 2 3 4 5
54, 46
42, 44
Figure 4. P12 enhanced platelet-derived growth factor receptor-b (PDGFR-b) activation, p85 recruitment to PDGFR, and prolonged Akt phosphorylation.
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shown as mean±SD.
J Zhu et al.
Fibronectin Peptide as Cofactor of PDGF-BB
926 Journal of Investigative Dermatology (2014), Volume 134
We believe that the absence of FN secondary to protease
degradation is one of the reasons that chronic wounds and
burns fail to heal (Wysocki et al., 1993; Grinnell and Zhu,
1996; Clark et al., 2003). It is possible that the deficiency in
growth factor activity in chronic wounds and burns is partially
secondary to the absence of FN growth factor–binding sites. If
this is so, administered P12 might increase growth factor
bioactivity to a level that would promote wound healing.
Multiple layered interactions between ECM and growth
factors have created a rapidly developing and complex field of
study. For example, ECM proteins in the cell microenviron-
ment can generate signals through integrins that act in synergy
with growth factor signaling (Schultz and Wysocki, 2009).
ECM can also bind soluble growth factors and regulate their
distribution, activation, and presentation to cells (Hynes,
2009). Specifically, growth factor–binding domains on FN
have been proposed to function as reservoir for growth factors
that provide spatial and temporal regulation for growth factor
signaling (Kim et al., 2011). Also, proteolytic processing of the
ECM proteins generate matrikines that directly activate growth
factor receptors (Tran et al., 2004). Our study demonstrates
that a growth factor–binding peptide from ECM can regulate
growth factor signaling by affecting growth factor endocytosis
and thereby enhance survival signals. This finding adds
another layer to the complexity between ECM and growth
factor signaling.
It has been demonstrated that some 10–20 residue, highly
cationic peptides can bring protein cargo into mammalian
cells through macropinocytosis (Wadia et al., 2004; Kaplan
et al., 2005; Al Soraj et al., 2012). Here, P12, a 14-residue,
highly cationic peptide, can bind PDGF-BB/PDGFR-b and
shift its entry into cells from dynamin-dependent endocytosis
to a macropinocytosis-like pathway. By entering the cell
through different endocytic pathways, growth factors can
generate differential signals because of the exposure to
unique adaptor and signal relay proteins in different cell
compartments (Wiley and Burke, 2001; Benmerah, 2004;
De Donatis et al., 2008; Chen, 2009). In this study, we
show that P12 while by itself does not affect PDGFR signaling
(Supplementary Figure S7 online), can bind to PDGF-BB and
shift PDGF-BB/PDGFR-b internalization to a dynamin-inde-
pendent, macropinocytosis-like pathway. As a consequence, it
transiently generates enhanced survival signals to promote
AHDF survival under stress. Importantly, P12 by itself does not
induce macropinocytosis (Supplementary Figure S4 online),
which is dependent on PI3K signaling from PDGF-BB
(Koivusalo et al., 2010).
Molecular modeling data have showed a potential binding
pocket of P12 is at the interface between PDGF-BB and
PDGFR-b (unpublished observations). Thus, as an alternative
to the CPP hypothesis, P12 at the interface between PDGF-BB
and PDGFR-b could induce conformational change in
PDGFR-b and thus affect downstream signaling. To test this
possibility, we have initiated a crystallography study to
determine whether P12 binding induces conformational
change in PDGF-BB/PDGFR-b complexes. Another possibility
is that P12 somehow slowed PDGFR degradation from
dynamin-dependent endocytosis and the slower degradation
of PDGFR-b is responsible for the sustained signaling from
PDGFR-b. As the ubiquitination state of PDGFR-b determines
the degradation and signal duration from PDGFR-b (Takayama
et al., 2005), one of the future studies will be to investigate if
the ubiquitination on PDGFR-b is affected by P12 treatment.
Regardless of the exact molecular mechanisms at play, our
findings here demonstrate a unique role for ECM proteins in
modulating growth factor signaling and cell survival.
In addition, these observations have important implications
for tissue engineering and for growth factor treatments of
wounds.
MATERIALS AND METHODS
Materials
P12, sP12 (scrambled P12), and C-terminal Cys-tagged P12 were
purchased from American Peptide (Sunnyvale, CA). Scrambled P12
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Figure 5. P12 rescued platelet-derived growth factor (PDGF) survival activity in clathrin heavy chain (CHC) knockdown (KD) cells. (a) CHC small interfering
RNA (siRNA) was used to KD CHC expression in adult human dermal fibroblast (AHDF) cells. The protein level dropped significantly after two consecutive
transfections (36 hours apart) with Hiperfect transfection reagents. (b) Mock cells were treated with 1 nM PDGF-BB±10mM P12 (sP12) in HBSS for 3 days and cell
metabolism was measured with XTT assay. Experiment was repeated three times (*Po0.05 compared with PDGF alone, n¼ 6). Error bar indicates SD. (c) CHC KD
cells were treated with 1 nM PDGF-BB±10mM P12 (sP12) in Hank’s balanced salt buffer (HBSS) for 3 days and cell metabolism was measured with XTT assay.
Experiment was repeated three times (*Po0.05 compared with PDGF alone, n¼ 6). Data are shown as mean±SD. GAPDH, glyceraldehyde-3-phosphate
dehydrogenase; OD, optical density.
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(sP12) is a synthetic peptide sharing same amino-acid composition as
P12 with scramble sequence. PDGF-BB was purchased from Invitro-
gen (#PHG0043; Carlsbad, CA). Antibody against PDGFR (#4564),
p-PDGFR-b (Tyr751; #3161), p-Akt (Ser473; #4058), p-c-Jun
N-terminal kinase (Thr183/Tyr185; #9251), p-extracellular signal–
regulated kinases 1/2 (Thr202/Tyr204; #4370), p-P38 (Thr180/Tyr182;
#9211), eIF4E (#2067) and glyceraldehyde-3-phosphate dehydrogen-
ase (#2118) are purchased from Cell Signaling Technology (Danvers,
MA). Antibody for PDGFR (ab32570) was purchased from Abcam
(Cambridge, MA). AHDF (CF31) primary cells are isolated from
dermis of a 31-year-old female. HBSS from Sigma (St Louis, MO).
Cell Proliferation kit II (XTT) and In Situ Cell Death Detection kit
(TUNEL reaction mixture) was purchased from Roche Diagnostics
(Indianapolis, IN). SiRNA for CHC KD (sc-35067) was purchased
from Santa Cruz Biotechnology (Dallas, TX). Allstar negative control
siRNA and Hiperfect transfection reagents were purchased from
Qiagen (Valencia, CA). EZ-Link Sulfo NHS-SS Biotinylation Kit was
purchased from Pierce (Rockford, IL).
Cell culture and transfections
AHDFs and MCF-7 were maintained in Dulbecco’s modified Eagle’s
medium (Gibco, Grand Island, NY) with 10% fetal bovine serum at
37 1C and 5% CO2 in a humidified atmosphere. AHDFs from passages
8 to 12 were used. For experimental conditions unless otherwise
indicated, P12 (sP12) was used at 10mM and PDGF-BB was used at
1 nM. SiRNA and mock was resuspended to 10mM before transfection.
Cells were transfected twice with Hiperfect Transfection Reagent
according to manufacturer’s recommendations at 36-hour intervals.
Peptide labeling
Cys-P12 was incubated with equal amount of Alexa Fluor 488 C5
maleimide at 100mM in 500 ul of phosphate-buffered saline for
2 hours at room temperature. Then it was purified by cation exchange
chromatography (CM-C50). The column was washed, and labeled
peptides were eluted with pH 11.5 HEPES buffer. The pH was
adjusted to 7.5 with HCl and concentration of P12-488 is determined
by OD280.
Confocal microscopy
CF31 cells grown in Lab-Tek Chamers were incubated with 1mM of
P12-Alexa488 for 1 hour at 37 1C, and washed. Plasma membranes
were stained with 5 ug ml–1 Cellmask Deep Red plasma membrane
stain for 2 minutes at 37 1C, fixed with 3.7% formaldehyde, and
analyzed by confocal microscopy (Zeiss LSM 510 META NLO Two-
Photon Laser Scanning Confocal Microscope System, Thornwood,
NY) with excitation light at 488 and 633 nm.
Flow cytometry
In all, 2 105 cells were incubated with 1 mM of P12-488
dissolved in Dulbecco’s modified Eagle’s medium. Subsequently,
cells were incubated for 2 minutes with 0.25% trypsin to detach
the cells and remove surface-bound peptide. For immunostaining
experiments, cells were treated with 1 nM PDGF±10 mM P12 for
1 hour then fixed with 3.7% formaldehyde and permeablized with
0.4% Triton-X100. Blocked with 1% BSA and stained with
primary and secondary antibodies each for 1 hour. Cells were
resuspended in phosphate-buffered saline and analyzed by flow
cytometer.
Separation of internalized PDGFR-b
Surface proteins were labeled with EZ-Link Sulfo NHS-SS Biotinyla-
tion Kit (contained a cleavable S-S to allow removal) following kit
instructions. The cells were prewarmed for 5 minutes at 37 1C,
followed by stimulation with 10 ng ml–1 PDGF-BB±P12 for the
indicated times in Figure 4. Cells were put on ice and remaining
surface-exposed biotin was removed by 20 mM sodium 2-mercap-
toethanesulfonate in 50 mM Tris followed by 20 mM iodoacetic acid
on ice. After cell lysis, biotinylated proteins were pulled down with
streptavidin agarose.
TUNEL staining
AHDF treated according to figure legend was fixed and permeabi-
lized in 0.1% Triton X-100 for 2 minutes at 4 1C, stained according to
kit protocol. Cell nuclei were stained with 4,6-diamidino-2-pheny-
lindole. Images were captured with a 10 , aperture 0.4 objective on
an inverted Diaphot-TMD fluorescent microscope (Nikon, Melville,
NY) using a CCD camera (Molecular Devices, Sunnyvale, CA).
Western blot
Cells were frozen and dissolved in lysis buffer from Cell Signaling
Technology (#9803) containing 20 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 1 mM Na2 EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium
pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na3VO4, 1mg ml
–1
leupeptin supplemented with 1 mM phenylmethylsulfonyl fluoride,
scraped, and sonicated, then spun and boiled in running buffer.
Equal amounts of protein were separated by 10% SDS-PAGE and
transferred onto nitrocellulose membranes. Membranes were
then blocked by 2% BSA in Tris buffered saline with Tween and
probed with primary antibodies over night at 4 1C. Horseradish
peroxidase–conjugated secondary antibodies were used for detection.
Images were taken with a Kodaq image station 440CF (Rochester,
NY). Intensity of the chemiluminescent signal was quantified by
Kodaq molecular imaging software v4.0.3.
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